Viewing Study NCT02125461

Main Search All Studies All Organizations Report Bug

Ignite Creation Date: 2025-12-24 @ 11:48 AM

Ignite Modification Date: 2025-12-24 @ 11:48 AM

Study NCT ID: NCT02125461

Status: COMPLETED

Last Update Posted: 2023-10-10

First Post: 2014-04-25

Is Possible Gene Therapy: False

Has Adverse Events: True

Brief Title: A Global Study to Assess the Effects of MEDI4736 Following Concurrent Chemoradiation in Patients With Stage III Unresectable Non-Small Cell Lung Cancer

Sponsor: AstraZeneca

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module Adverse Events Module Baseline Characteristics Module Participant Flow Module